Anebulo Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
ANEB Anebulo Pharmaceuticals Inc
APA APA Corp (US)
CHI Calamos Convertible Opportunities and Income Fund
AAPL Apple Inc
ESI Element Solutions Inc
STXB Spirit of Texas Bancshares Inc
ED Consolidated Edison Inc
SNAP Snap Inc
THQ Tekla Healthcare Opportunities Fund
TGIOY Tung Ho Steel Enterprise Corp
Go

Health Care : Pharmaceuticals |
Company profile

Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing solutions for people suffering from cannabinoid overdose and substance addiction. The Company's lead product candidate, ANEB-001, is a potent, small molecule cannabinoid receptor antagonist, designed to address the unmet medical need for a specific antidote for cannabinoid overdose. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations. ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within one hour of administration. CB1 antagonists bind to the CB-1 receptor and thereby reverse the action of cannabinoids such as tetrahydrocannabinol (THC). It has completed Phase I trials.

Closing Price
$6.42
Day's Change
0.07 (1.10%)
Bid
--
Ask
--
B/A Size
--
Day's High
6.42
Day's Low
6.42
Volume
384
  • Prev Close
    6.35
  • Today's Open
    6.42
  • Day's Range
    6.42-6.42
  • Avg Vol (10-day)
    6.1K
  • Last (time)
    9:30a ET 10/28/21
  • Last (size)
    51
  • 52-Wk Range
    6.22 - 9.33
    LowHigh
  • (05/21/21 - 10/27/21)
    3.22%
  • 58.3%
  • Market Cap
    149.9M
  • Shares Outstanding
    23.3M
  • -1.64
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 18.01
  • (% of float 10/15/21)
    0.16

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.